Molecular testing in cell lines exhibited that the ESR1 gene was lower expressed in all four EOC cell lines, which could be upregulated by NFE2L2 silencing in the subsequently NFE2L2-downregulated cancer cell lines. The gene discussed is ESR1; the disease is cancer.